Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
Vairavan Latha sold 435 Arcutis Biotherapeutics, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 13, 2026
On May 11, 2026, Vairavan Latha (SVP Chief Financial Officer) sold 435 Arcutis Biotherapeutics, Inc. shares at US$21.05 for US$9,157 under a trading plan, leaving 85,978 shares. Filed May 13, 2026 (Form 4).
- Sold
- 435 shares
- Price
- US$21.05
- Value
- US$9,157
- Holding after
- 85,978 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Sale | 435 | US$21.05 | 85,978 | Direct |
Source
Related
- Arcutis Biotherapeutics, Inc.
- Vairavan Latha
- Arcutis Biotherapeutics, Inc. shareholders
- Form 4 · Vairavan Latha · May 6, 2026
- Form 4 · Welgus Howard G. · Oct 19, 2026
- Schedule 13G/A · BlackRock, Inc. · Oct 5, 2026
- Form 4 · Matsuda Masaru · Sep 18, 2026
- Form 4 · Welgus Howard G. · Sep 17, 2026
- Form 4 · Matsuda Masaru · Sep 10, 2026